Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

南京科恩里斯生物医药有限公司(P.S.K Biosciences)是基于江苏先声药业的原转化医学与创新药物国家重点实验室外泌体载药技术平台,创立的平台类生物技术公司。聚焦外泌体靶向递送能力的建立,特别是核酸类药物透脑及肿瘤组织靶向递送;同时,关注老年人所面临的广阔的、未被满足临床治疗需求,利用间充质干细胞来源外泌体(天然外泌体)独立开展创新药开发。科恩里斯生物秉承着“让生命更长久更健康”的愿景,致力于解决创新药开发遇到的药物靶向递送瓶颈的同时,推动天然外泌体药物的临床转化。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

科恩里斯 Financing History (1 rounds)

Manage
A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 数千万人民币
  • Investor: 联想创投,南京玄武高新投资...

科恩里斯 How Fast Is Hiring Growing?

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 40%
  • 2024: Up 25%
科恩里斯 Year-by-Year Hiring:
科恩里斯 Campus Recruitment & Advanced Degree Talent Demand
Master's 4 Doctorate 2
Note: How fast is hiring at 南京科恩里斯生物医药有限公司 growing? 科恩里斯2025: 7 openings (up 40%), 2024: 5 openings (up 25%), 2023: 4 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

科恩里斯 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 50%
  • 2024: Up 300%
科恩里斯 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 南京科恩里斯生物医药有限公司 growing? 科恩里斯Master's recruitment over the years: 2025: 2 openings (down 50%), 2024: 4 openings (up 300%), 2023: 1 openings.

科恩里斯 Doctoral Degree Job Demand Analysis

(More)
Flat
Growth Rate
2026 vs 2025
  • 2025: Up 100%
  • 2024: Flat 0%-
科恩里斯 Doctoral Hiring by Year: 2026 — same as 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 南京科恩里斯生物医药有限公司 growing? 科恩里斯Doctorate recruitment over the years: 2026: 2 openings (flat), 2025: 2 openings (up 100%), 2024: 1 openings (flat), 2023: 1 openings.

科恩里斯 — What Are the Salaries Like? (16 records)

Manage
科恩里斯 Salary Overview
salary range: 10K - 50K, 62.5% of roles pay ¥20-50K
Note: salary statistics are based on 16 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 南京科恩里斯生物医药有限公司?科恩里斯62.5% of positions earn 20-50K, Undergraduate salary: ¥。Nanjing salary ranking top 10,生物/制药/化工/环保类 average salary ¥35.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

科恩里斯 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

科恩里斯 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 生物/制药/化工/环保类
    50% of total 50%
  • 经营管理类
    50% of total 50%
  • 质量管理类
    43.8% of total 43.8%
  • 其他(研发和技术类)
    31.3% of total 31.3%

Education

  • 硕士
    43.8% of total 43.8%
  • 本科
    31.3% of total 31.3%
  • 博士
    25% of total 25%

Experience

  • 5-10年
    43.8% of total 43.8%
  • 3-5年
    43.8% of total 43.8%
  • 1-3年
    12.5% of total 12.5%
View Detailed Analysis

What does 南京科恩里斯生物医药有限公司 require? Who is 科恩里斯 hiring? 科恩里斯 recruitment: 生物/制药/化工/环保类占比最多占50%,其次是经营管理类占50%. What education can get in at 科恩里斯? 硕士占比最多占43.8%,其次是本科占31.3%. High education required at 科恩里斯? 硕士占43.8%,博士占25%. Work experience required at 科恩里斯? 5-10年占比最多占43.8%,其次是3-5年占43.8%. Where are the job locations at 科恩里斯? 南京占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 955.5555万(元)
Legal Representative: 吴庭鹤
Date Established:
Credit Code: 91320102MACN9PX159
Registered Address: 南京市玄武区玄武大道699-18号5幢311室

People who follow 科恩里斯 also follow

科恩里斯 Competitors (Similar Companies)

生物科技/生物工程 药物研发 新药研发 药物评价
功能食品 生产 化妆品 日化
医药 原料药 药物研发 辛伐他汀
设计
生物智能 药物研发 生物医药 临床研究
“Gathering talents from around the world, building a global stage”
“专注于自有知识产权的抗体创新药物研发”
“Promoting high-quality development of biomedicine and health industry”
基因合成 合成仪 研发 细胞技术
医药 药物研发 研发 医药研发
生物科技/生物工程
“Helping patients access more effective medicines sooner”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates